14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Apr 22, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 21, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 20, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 19, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 18, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 14, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 13, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 12, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 11, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 08, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 07, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 06, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 05, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 04, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 01, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 31, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 30, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 29, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 28, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 25, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 24, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 23, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 22, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 21, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 18, 2022 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT